menu search

RLYB / Wall Street Analysts Believe Rallybio Corporation (RLYB) Could Rally 202.36%: Here's is How to Trade

Wall Street Analysts Believe Rallybio Corporation (RLYB) Could Rally 202.36%: Here's is How to Trade
The mean of analysts' price targets for Rallybio Corporation (RLYB) points to a 202.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. Read More
Posted: May 29 2023, 11:05
Author Name: Zacks Investment Research
Views: 102025

RLYB News  

Rallybio: Gearing Up To Be An Opportunity

By Seeking Alpha
September 15, 2023

Rallybio: Gearing Up To Be An Opportunity

Rallybio has proof of concept data from two more assets, RLYB211 and RLYB116, in addition to their lead asset RLYB212. RLYB212 demonstrated rapid and more_horizontal

Wall Street Analysts Believe Rallybio Corporation (RLYB) Could Rally 202.36%: Here's is How to Trade

By Zacks Investment Research
May 29, 2023

Wall Street Analysts Believe Rallybio Corporation (RLYB) Could Rally 202.36%: Here's is How to Trade

The mean of analysts' price targets for Rallybio Corporation (RLYB) points to a 202.4% upside in the stock. While this highly sought-after metric has more_horizontal

Rallybio to Present at Upcoming Investor Conferences in March

By Business Wire
March 1, 2023

Rallybio to Present at Upcoming Investor Conferences in March

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerati more_horizontal

Rallybio to Present at the JMP Securities Hematology and Oncology Summit

By Business Wire
November 29, 2022

Rallybio to Present at the JMP Securities Hematology and Oncology Summit

NEW HAVEN, Conn.--( BUSINESS WIRE )--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelera more_horizontal


Search within

Pages Search Results: